Cheelcare Posts 22% Revenue Growth but Losses Widen; Curio ADP Listing Delayed
CHCRF is trading near its 52-week low of $0.655 (0.0% above the low).
Summary
Cheelcare reported fiscal 2026 revenue of $1.9M, up 22% year-over-year, but net loss widened to $4.86M from $1.27M. Gross margin fell to 24% from 42% due to a $443K inventory write-off and labor reclassification. Q4 revenue jumped 78% to $628K, but the quarter saw a gross loss of $185K. The Curio robotic wheelchair's Ontario ADP listing is delayed as the company undertakes additional product refinement and validation; first commercial units were delivered in March 2026. The company completed a $3.02M private placement in July 2026 at $1.50 per unit. The widening losses and Curio delay are likely to pressure the stock, though revenue growth and Medicare/Medicaid reimbursement for Companion provide some offset.
At the time of this announcement, CHCRF was trading at $0.66 on OTC in the Manufacturing sector. The 52-week trading range was $0.66 to $0.66. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.